The use of GnRH analogues for the induction of LH surge and oocyte maturation in controlled ovarian hyperstimulation

被引:0
|
作者
Itskovitz-Eldor, J [1 ]
机构
[1] Technion Israel Inst Technol, Rambam Med Ctr, Dept Obstet & Gynecol, Fac Med, Haifa, Israel
来源
INFERTILITY AND ASSISTED REPRODUCTIVE TECHNOLOGY: FROM RESEARCH TO THERAPY | 1997年
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:279 / 285
页数:7
相关论文
共 50 条
  • [1] Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation
    Ghofranian, Atoosa
    Estevez, Samantha L.
    Dubois, Bethany
    Gellman, Caroline
    Gounko, Dmitry
    Lee, Joseph A.
    Copperman, Alan B.
    Thornton, Kimberly
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2024, 41 (08) : 1991 - 1996
  • [2] USE OF GNRH ANALOG FOR INDUCTION OF THE OVULATORY SURGE OF GONADOTROPINS IN PATIENTS AT RISK OF THE OVARIAN HYPERSTIMULATION SYNDROME
    KULIKOWSKI, M
    WOLCZYNSKI, S
    KUCZYNSKI, W
    GROCHOWSKI, D
    SZAMATOWICZ, M
    GYNECOLOGICAL ENDOCRINOLOGY, 1995, 9 (02) : 97 - 102
  • [3] GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
    Alama, Pilar
    Bellver, Jose
    Vidal, Carmen
    Giles, Juan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 11 (02) : 107 - 116
  • [4] Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation
    Christin-Maitre, S
    Olivennes, F
    Dubourdieu, S
    Chabbert-Buffet, N
    Charbonnel, B
    Frydman, R
    Bouchard, P
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 721 - 726
  • [5] A case of ovarian hyperstimulation syndrome using GnRH agonist to trigger oocyte maturation after cotreatment with GnRH antagonist
    Kovachev, E.
    13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 329 - 332
  • [6] Impact of different amounts of LH in controlled ovarian hyperstimulation oocyte donation cycles.
    Bosch, E.
    Pau, E.
    Albert, C.
    Zuzuarregui, J.
    Remohi, J.
    Pellicer, A.
    FERTILITY AND STERILITY, 2006, 86 : S425 - S425
  • [7] GnRH agonist versus GnRH antagonist during controlled ovarian hyperstimulation (COH): Is there an effect on oocyte maturity and aneuploidy
    Ghadir, S
    Sarajari, S
    Kumar, A
    Li, M
    Hill, D
    Danzer, H
    Surrey, M
    FERTILITY AND STERILITY, 2005, 83 : S15 - S15
  • [8] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
    Kol, S.
    Solt, I.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (2-3) : 63 - 66
  • [9] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
    S. Kol
    I. Solt
    Journal of Assisted Reproduction and Genetics, 2008, 25 : 63 - 66
  • [10] Pregnancy and Birth After GnRH Agonist Treatment for Induction of Final Oocyte Maturation in a Woman Undergoing Ovarian Stimulation for ICSI, Using a GnRH Antagonist (Orgalutran/Antagon) to Prevent a Premature LH Surge: A Case Report
    Diederick de Jong
    Eric G. van Hooren
    Nicholas S. Macklon
    Bernadette M. J. L. Mannaerts
    Bart C. J. M. Fauser
    Journal of Assisted Reproduction and Genetics, 2001, 18 : 30 - 33